Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

American Journal of Epidemiology

Volumn 156, Issue 11, 2002, Pages 1070-1077

  Laaksonen, David E ^a,b   Lakka, Hanna Maaria ^b   Niskanen, Leo K ^a   Kaplan, George A ^c   Salonen, Jukka T ^b,d   Lakka, Timo A ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF MICHIGAN   (United States)

^d Inner Savo Health Centre   (Finland)

Author keywords

Diabetes mellitus; Hyperinsulinism; Hyperlipidemia; Hypertension; Insulin resistance; Obesity

Indexed keywords

DIABETES; METABOLISM;

ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DIABETES MELLITUS; EDUCATION PROGRAM; FINLAND; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; PREDICTION; PREVALENCE; SENSITIVITY ANALYSIS; SYNDROME DELINEATION; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

EID: 0036891935     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwf145     Document Type: Article

References (24)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
2. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: An epidemiologic perspective. Epidemiol Rev 1998;20:157-72.
3. Bouchard C. Genetics and the metabolic syndrome. Int J Obes Relat Metab Disord 1995;19(suppl 1):S52-9.
4. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
5. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
6. Hodge AM, Dowse GK, Zimmet PZ. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus. Diabet Med 1996;13:441-9.
7. Zavaroni I, Bonini L, Gasparini P, et al. Dissociation between urinary albumin excretion and variables associated with insulin resistance in a healthy population. J Intern Med 1996;240:151-6.
8. Jager A, Kostense PJ, Nijpels G, et al. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: The Hoorn Study. Diabetologia 1998;41:694-700.
9. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999;16:442-3.
10. Folsom AR, Kushi LH, Anderson KE, et al. Associations of general and abdominal obesity with multiple health outcomes in older women: The Iowa Women's Health Study. Arch Intern Med 2000;160:2117-28.
11. Seidell JC, Oosterlee A, Deurenberg P, et al. Abdominal fat depots measured with computed tomography: Effects of degree of obesity, sex, and age. Eur J Clin Nutr 1988;42:805-15.
12. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
13. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Guidelines Subcommittee. J Hypertens 1999;17:151-83.
14. Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: Problems and prospects. Endocr Rev 1998;19:477-90.
15. Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res 1988;20:46-50.
16. Salonen JT, Lakka TA, Lakka HM, et al. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes 1998;47:270-5.
17. Salonen JT, Tuomainen TP, Kontula K. Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: Prospective cohort study. BMJ 2000;320: 1706-7.
18. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85:2402-10.
19. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. Geneva, Switzerland: World Health Organization, 2000. (WHO technical report series, 894).
20. National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, MD: Department of Health and Human Services, National Institutes of Health, 1998. (NIH publication no. 98-4083).
21. Han TS, van Leer EM, Seidell JC, et al. Waist circumference action levels in the identification of cardiovascular risk factors: Prevalence study in a random sample. BMJ 1995;311:1401-5.
22. Chan JM, Rimm EB, Colditz GA, et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994;17:961-9.
23. Niskanen LK, Tuomi T, Karjalainen J, et al. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis. Diabetes Care 1995;18:1557-65.
24. Lebovitz HE. Type 2 diabetes: An overview. Clin Chem 1999; 45:1339-45.